5%+ stake
6.6%Stake
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Loading…
HSIC · NASDAQ · Health Care Distributors
Health Care Distributors company based in Melville, New York.
Last close, Oct 1, 2026
$84.93
Adjusted for splits and dividends
Last 12 months
+29.5%
S&P 500 +14.3% over the same dates
Market value
$9.47B
Last close × shares outstanding
Bets against the stock: 7.57M shares sold short (6.8% of shares outstanding), -7.0% vs the previous count, 8.3 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$13.2B
+4.0% vs the year before
Net income, fiscal 2025
$398M
As reported in the annual filing
Shares outstanding
111M
As of Jul 27, 2026
In fiscal 2025 the company spent $850M buying back its own shares. Cash actually paid, from its cash-flow statement.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Stock since the trade +23.1% · S&P 500 +3.3% · to Oct 1Traded 6 days after results
10K → 20K shares held+100% of their stake
A board member of Henry Schein spent $692K of their very own money to buy Henry Schein shares. Their pile of Henry Schein shares grew by 100%.
Stock since the trade +16.9% · S&P 500 +15.8% · to Oct 1Traded 23 days after results
88K → 86K shares held−2% of their stake
The boss of Henry Schein sold $99K of Henry Schein shares. Nobody planned it ahead of time.
Stock since the trade +11.3% · S&P 500 +12.8% · to Oct 1Traded 14 days after resultsStock 23% above its 52-week low and 8% below its high
18K → 15K shares held−16% of their stake
A board member of Henry Schein sold $225K of Henry Schein shares. Nobody planned it ahead of time.
An amended Schedule 13D: the activist holder's stake changed by at least half a point.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Short sale volume: 60.0% of the volume reported to FINRA over the last 20 trading days was marked short, close to its 1-year average of 58.4%. FINRA daily files, to Oct 2, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.
0 approvals or clearances and 2 recalls recorded by the FDA for this company and its listed subsidiaries.
From openFDA: Drugs@FDA (new applications and new uses), device 510(k) and PMA decisions, and FDA enforcement reports. Class I recalls are the most serious, Class III the least. Most recalls are started by the company itself. Labeling and manufacturing changes are not listed.
Last 12 months, adjusted daily closes
Adjusted close went from $65.60 on Oct 1, 2025 to $84.93 on Oct 1, 2026 (+29.5%). Disclosed trades in the last 12 months: 1 insider purchase, 10 insider sales, 0 Congress purchases, 0 Congress sales.
KKR Group Partnership L.P.
Schedule 13D: may seek to influence the company · filed Mar 10, 2026 · 18.9M shares
FMR LLC
Schedule 13G: passive · filed Aug 6, 2026 · 7.55M shares
Vanguard Capital Management
Schedule 13G: passive · filed Apr 30, 2026 · 7.3M shares
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.
1 certified in FY2026 Q3, vs 1 a year earlier. 1 position in total, median offered wage $150K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Top officer leaving
“Lowery commences employment with the Company, and then following his retirement as Chief Executive Officer Mr.”
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.